cSRC-Abl inhibitors (University of Siena)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NamecSRC-Abl inhibitors (University of Siena)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase SRC inhibitorsBcr-Abl tyrosine kinase inhibitors
TargetsBcr-Abl tyrosine kinaseTyrosine-protein kinase SRC
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Siena
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Siena
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A